Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Wiley 2018-07-01
Reeks:	Reproductive Medicine and Biology
Onderwerpen:	assisted reproductive technology atypical endometrial hyperplasia conservative treatment endometrial carcinoma medroxyprogesterone acetate
Online toegang:	https://doi.org/10.1002/rmb2.12209

Gelijkaardige items

Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
door: Vakkas Korkmaz, et al.
Gepubliceerd in: (2013-08-01)

Results of surgical treatment of atypical endometrial hyperplasia
door: O. A. Gornykh, et al.
Gepubliceerd in: (2014-07-01)

Modern approaches to the diagnosis of endometrial hyperplasia
door: M. M. Damirov, et al.
Gepubliceerd in: (2025-02-01)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
door: А. E. Protasova, et al.
Gepubliceerd in: (2024-07-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
door: An-Ju Chou, et al.
Gepubliceerd in: (2024-11-01)

Endometrial hyperplasia and progesterone resistance: a complex relationship
door: Mekan R. Orazov, et al.
Gepubliceerd in: (2023-03-01)

The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study
door: Lana G. Dzhanashvili, et al.
Gepubliceerd in: (2022-09-01)

Trans-vaginal sono-elastography in the differentiation of endometrial hyperplasia and endometrial carcinoma
door: Mahmoud Abdel Latif, et al.
Gepubliceerd in: (2016-09-01)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
door: Fariba Behnamfar, et al.
Gepubliceerd in: (2014-01-01)

Reproductive advance of fertility preservation in patients with early endometrial carcinoma or endometrial atypical hyperplasia
door: Jiao Yu, et al.
Gepubliceerd in: (2022-12-01)

Laparoscopic surgery for atypical endometrial hyperplasia with awareness regarding the possibility of endometrial cancer
door: Misato Kamii, et al.
Gepubliceerd in: (2023-01-01)

Features of the course of pregnancy and childbirth after conservative treatment of initial atypical hyperplasia and endometrial cancer
door: A. V. Charkhifalakyan, et al.
Gepubliceerd in: (2025-01-01)

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women
door: Stefano Uccella, et al.
Gepubliceerd in: (2022-09-01)

The retrospective analysis results of the endometrial tissue pathological conditions development
door: V. V. Artyomenko, et al.
Gepubliceerd in: (2020-11-01)

Recurrent endometrial atypical hyperplasia diagnosed by pathological examination of the placenta from a live birth: a case report
door: Weilu Wu, et al.
Gepubliceerd in: (2023-09-01)

Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia
door: Pinar Kadirogullari, et al.
Gepubliceerd in: (2015-10-01)

Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes
door: Xu S, et al.
Gepubliceerd in: (2025-02-01)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
door: Junyu Chen, et al.
Gepubliceerd in: (2021-09-01)

Liquid-based endometrial cytology associated with curettage in the investigation of endometrial carcinoma in postmenopausal women
door: Ke Ma, et al.
Gepubliceerd in: (2016-12-01)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
door: Jun Guan, et al.
Gepubliceerd in: (2022-10-01)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
door: Junyu Chen, et al.
Gepubliceerd in: (2022-02-01)

Clinical features and outcome of 15 patients with recurrent endometrial cancer or atypical endometrial hyperplasia received primary fertility-sparing therapy followed by hysterectomy
door: Yuanting Li, et al.
Gepubliceerd in: (2021-03-01)

The proliferation markers in patients with different forms of hyperplastic endometrial processes
door: Yuri Krut, et al.
Gepubliceerd in: (2022-05-01)

Risk of endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia treated with total laparoscopic hysterectomy
door: Katsutoshi Oda, et al.
Gepubliceerd in: (2016-05-01)

Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
door: Xinxin Zhu, et al.
Gepubliceerd in: (2023-12-01)

Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia
door: Yu-Li Chen, et al.
Gepubliceerd in: (2009-06-01)

Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia
door: Pengfei Wu, et al.
Gepubliceerd in: (2024-01-01)

ENDOMETRIAL PRECANCER: DEFINITION OF CONCEPTS, TACTICS
door: Iu. Iu. Tabakman, et al.
Gepubliceerd in: (2016-09-01)

Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors
door: Luca Giannella, et al.
Gepubliceerd in: (2020-07-01)

Evaluation of Diagnostic Efficacy of Pipelle Endometrial Sampling in Abnormal Uterine Bleeding
door: ABILASH SASIDHARANNAIR CHANDRAKUMARI, et al.
Gepubliceerd in: (2018-05-01)

Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases
door: Junyu Chen, et al.
Gepubliceerd in: (2024-06-01)

Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment
door: Yaxing Guo, et al.
Gepubliceerd in: (2022-06-01)

Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery <sup>†</sup>
door: Yaochen Lou, et al.
Gepubliceerd in: (2021-12-01)

Clinical, Sonographic, and Hysteroscopic Features of Endometrial Carcinoma Diagnosed after Hysterectomy in Patients with a Preoperative Diagnosis of Atypical Hyperplasia: A Single-Center Retrospective Study
door: Luca Pace, et al.
Gepubliceerd in: (2022-12-01)

New classification system of endometrial hyperplasia WHO 2014 and its clinical implications
door: Katarzyna Sobczuk, et al.
Gepubliceerd in: (2017-10-01)

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia
door: Steven Wang, MD, et al.
Gepubliceerd in: (2015-03-01)

Age-related relationship between the development of hyperplastic processes and VEGF expression in endometrial cells
door: Z. V. Chumak, et al.
Gepubliceerd in: (2020-04-01)

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
door: Jin-Sung Yuk
Gepubliceerd in: (2016-08-01)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
door: Lee Shi Hui, et al.
Gepubliceerd in: (2021-05-01)

Effects of isoflavone supplementation on endometrial thickness, endometrial hyperplasia, and cancer in ovariectomized cats
door: Mona Negadmonfared, et al.
Gepubliceerd in: (2022-01-01)